These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38514100)

  • 1. Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study.
    De Vitis LA; Fumagalli D; Schivardi G; Capasso I; Grcevich L; Multinu F; Cucinella G; Occhiali T; Betella I; Guillot BE; Pappalettera G; Shahi M; Fought AJ; McGree M; Reynolds E; Colombo N; Zanagnolo V; Aletti G; Langstraat C; Mariani A; Glaser G
    Int J Gynecol Cancer; 2024 May; 34(5):689-696. PubMed ID: 38514100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
    Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
    Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
    Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
    Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.
    Kim CH; Khoury-Collado F; Barber EL; Soslow RA; Makker V; Leitao MM; Sonoda Y; Alektiar KM; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2013 Dec; 131(3):714-9. PubMed ID: 24099838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer.
    Baiocchi G; Mantoan H; Gonçalves BT; Faloppa CC; Kumagai LY; Badiglian-Filho L; da Costa AABA; De Brot L
    Ann Surg Oncol; 2020 May; 27(5):1589-1594. PubMed ID: 31686340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging.
    Kim CH; Soslow RA; Park KJ; Barber EL; Khoury-Collado F; Barlin JN; Sonoda Y; Hensley ML; Barakat RR; Abu-Rustum NR
    Int J Gynecol Cancer; 2013 Jun; 23(5):964-70. PubMed ID: 23694985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer.
    Matsuo K; Klar M; Khetan VU; Violette CJ; Youssefzadeh AC; Yessaian AA; Roman LD
    Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():91-96. PubMed ID: 35763967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Micrometastases in sentinel lymph node in endometrial cancer patients].
    Sawicki S; Kobierski J; Liro M; Wojtylak S; Lass P; Wydra D
    Ginekol Pol; 2015 Apr; 86(4):262-7. PubMed ID: 26117984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Volume Lymph Node Metastases in Endometrial Carcinoma.
    Clinton LK; Kondo J; Carney ME; Tauchi-Nishi P; Terada K; Shimizu D
    Int J Gynecol Cancer; 2017 Jul; 27(6):1165-1170. PubMed ID: 28604450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node intraoperative analysis in endometrial cancer.
    Bellaminutti S; Bonollo M; Gasparri ML; Clivio L; Migliora P; Mazzucchelli L; Papadia A
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3199-3205. PubMed ID: 32815026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer.
    Cabrera S; Gómez-Hidalgo NR; García-Pineda V; Bebia V; Fernández-González S; Alonso P; Rodríguez-Gómez T; Fusté P; Gracia-Segovia M; Lorenzo C; Chacon E; Roldan Rivas F; Arencibia O; Martí Edo M; Fidalgo S; Sanchis J; Padilla-Iserte P; Pantoja-Garrido M; Martínez S; Peiró R; Escayola C; Oliver-Pérez MR; Aghababyan C; Tauste C; Morales S; Torrent A; Utrilla-Layna J; Fargas F; Calvo A; Aller de Pace L; Gil-Moreno A;
    Ann Surg Oncol; 2023 Nov; 30(12):7653-7662. PubMed ID: 37633852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).
    Altin D; Taşkın S; Kahramanoglu I; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Naki MM; Güngör M; Köse MF; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Jul; 30(7):1005-1011. PubMed ID: 32474451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
    Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
    Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological factors associated with non-sentinel lymph node metastasis in early stage cervical cancer.
    Diniz TP; Faloppa CC; Mantoan H; Gonçalves BT; Kumagai LY; Menezes ANO; Badiglian-Filho L; Guimaraes APG; da Costa AABA; De Brot L; Baiocchi G
    J Surg Oncol; 2021 Mar; 123(4):1115-1120. PubMed ID: 33524165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.